QNRX — 4 insiders, all buying

Form 4 lag: insiders have 2 business days to file after a trade (weekends and holidays extend this), and this site re-ingests once daily — a transaction can appear here roughly three business days after it happened.
13F lag: quarterly 13F-HR holdings cover the prior quarter-end and are due 45 days after it — every institutional position shown here is at least 45 days old by construction, often more.
CUSIP→ticker gaps: 13F positions are reported by CUSIP; some holdings cannot be matched to a current ticker (delistings, corporate actions, thin metadata) and appear without one or are omitted from ticker-level views.
EDGAR timing variability: institutions file at different hours and days within their windows; amended filings (4/A, 13F-HR/A) can restate earlier periods, so historical aggregates may change between batches.

Quoin Pharmaceuticals, Ltd. · Materials · ISO week 2026-W36 (2026-08-31 → 2026-08-31)

WATCH + all buys · clu-00ca6f81a081 · detected 2026-09-02

4Distinct insiders

8Transactions

+$280kTotal reported value

4Source filings

Members

Insider	Role	Txns	Reported value
Carter Denise P.	Chief Operating Officer	2	$100k
Myers Michael	Chief Executive Officer	2	$100k
Lawlor Sally Bridget	Chief Financial Officer	2	$50k
Culverwell Anthony James	Director	2	$30k

+ Carter Denise P. Chief Operating Officer P 20,490 sh @ $4.88 = $100k 0001104659-26-104405
+ Carter Denise P. Chief Operating Officer P 10,245 sh (derivative) 0001104659-26-104405
+ Myers Michael Chief Executive Officer P 20,490 sh @ $4.88 = $100k 0001104659-26-104404
+ Myers Michael Chief Executive Officer P 10,245 sh (derivative) 0001104659-26-104404
+ Lawlor Sally Bridget Chief Financial Officer P 10,244 sh @ $4.88 = $50k 0001104659-26-104403
+ Lawlor Sally Bridget Chief Financial Officer P 5,122 sh (derivative) 0001104659-26-104403
+ Culverwell Anthony James Director P 6,146 sh @ $4.88 = $30k 0001104659-26-104402
+ Culverwell Anthony James Director P 3,073 sh (derivative) 0001104659-26-104402